Woodcock A, Vestbo J, Bakerly ND, et al. Effectiveness of fluticasone furoate plus vilanterol on asthma control in clinical practice: an open-label, parallel group, randomised controlled trial. Lancet 2017; 390: 2247–55—In table 1 of this Article (published Online First on Sept 10, 2017), the number of patients in the fluticasone furoate and vilanterol group who did not have any exacerbations in the previous year before randomisation should be 1378. In figure 3, the data should be as follows: HR=0·96 (95% CI 0·86–1·07); p=0·5041.

中文翻译：

---

错误部

Woodcock A，Vestbo J，Bakerly ND等。临床实践中糠酸氟替卡松加维兰特罗对哮喘控制的有效性：一项开放标签，平行分组，随机对照试验。柳叶刀2017; 390： 2247–55 —在本文的表1中（于2017年9月10日在线第一版发布），氟替卡松糠酸酯和维兰特罗组的患者在前一年未加重前的随机数应为1378。在图3中，数据应如下所示：HR = 0·96（95％CI 0·86-1·07）；p = 0·5041。